Markets:

Overview

News

Currencies

International

Treasuries

Monopar Therapeutics Inc. - Common Stock (NQ:MNPR)

77.10 -0.08 (-0.10%)

Streaming Delayed Price Updated: 12:49 PM EST, Dec 4, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Monopar Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Monopar Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying ↗

June 03, 2024

Via Benzinga

Monopar Announces CFO Succession

May 24, 2024

From Monopar Therapeutics Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 09, 2024

Via Benzinga

MNPR Stock Earnings: Monopar Therapeutics Beats EPS for Q1 2024 ↗

May 09, 2024

MNPR stock results show that Monopar Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline

May 09, 2024

From Monopar Therapeutics Inc.

Via GlobeNewswire

Recap: Monopar Therapeutics Q4 Earnings ↗

March 28, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

May 03, 2024

Via Benzinga

Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting

April 18, 2024

From Monopar Therapeutics Inc.

Via GlobeNewswire

Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings

April 16, 2024

From Monopar Therapeutics Inc.

Via GlobeNewswire

Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients

April 10, 2024

From Monopar Therapeutics Inc.

Via GlobeNewswire

MNPR Stock Earnings: Monopar Therapeutics Beats EPS for Q4 2023 ↗

March 28, 2024

MNPR stock results show that Monopar Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments

March 28, 2024

From Monopar Therapeutics Inc.

Via GlobeNewswire

Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program

March 05, 2024

From Monopar Therapeutics Inc.

Via GlobeNewswire

Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 19, 2024

Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results.

Via Benzinga

Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial

February 27, 2024

From Monopar Therapeutics Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

February 26, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

February 23, 2024

Via Benzinga

Crude Oil Down 2%; Maravai LifeSciences Shares Spike Higher ↗

February 23, 2024

U.S. stocks traded mostly higher midway through trading, with the Dow Jones index jumping more than 100 points on Friday. The Dow traded up 0.36% to 39,209.32 while the NASDAQ rose 0.01% to 16,042.80....

Via Benzinga

Topics Stocks

Dow Surges Over 150 Points; AerCap Posts Upbeat Earnings ↗

February 23, 2024

U.S. stocks traded higher this morning, with the Dow Jones index jumping more than 150 points on Friday.

Via Benzinga

Topics Stocks

Dow Gains Over 400 Points; Keurig Dr Pepper Shares Fall After Q4 Results ↗

February 22, 2024

U.S. stocks traded higher toward the end of trading, with the Dow Jones index jumping more than 400 points on Thursday. The Dow traded up 1.13% to 39,048.47 while the NASDAQ rose 2.93% to 16,037.52....

Via Benzinga

Topics Stocks

Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 22, 2024

Shares of Etsy, Inc.

Via Benzinga

What's Going On With Cancer-Focused Monopar Therapeutics Stock Today? ↗

February 22, 2024

Monopar Therapeutics soars 36% in premarket trading on robust volume. Exciting preclinical data reveals MNPR-101's potent anti-tumor efficacy in targeting uPAR-expressing cancers.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 22, 2024

Via Benzinga

Crude Oil Rises 1%; US Jobless Claims Fall To 201,000 ↗

February 22, 2024

U.S. stocks traded higher midway through trading, with the Nasdaq Composite jumping around 300 points on Thursday. The Dow traded up 0.67% to 38,872.01 while the NASDAQ rose 2.36% to 15,949.22. The S&P...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 22, 2024

Via Benzinga

Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers

February 22, 2024

From Monopar Therapeutics Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 21, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 20, 2024

Via Benzinga

Crude Oil Moves Lower; Summit Therapeutics Shares Plummet ↗

February 20, 2024

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 200 points on Tuesday. The Dow traded down 0.18% to 38,557.86 while the NASDAQ fell 1.30% to 15,570.84. The...

Via Benzinga

Topics Stocks

Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 20, 2024

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.